Home >> Infectious Diseases >> Infectious Diseases >> Baked Goods >> Technology & Media >>

Yellow Fever - Pipeline Review, H1 2015

Published: Apr-2015 | Format: PDF | Global Markets Direct | Number of pages: 56 | Code: MRS - 18268

Yellow Fever - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Yellow Fever - Pipeline Review, H1 2015’, provides an overview of the Yellow Fever’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Yellow Fever, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Yellow Fever and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Yellow Fever
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved in the therapeutics development for Yellow Fever and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects 
- A review of the Yellow Fever products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Yellow Fever pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Yellow Fever
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Yellow Fever pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Yellow Fever Overview 7
Therapeutics Development 8
Pipeline Products for Yellow Fever - Overview 8
Pipeline Products for Yellow Fever - Comparative Analysis 9
Yellow Fever - Therapeutics under Development by Companies 10
Yellow Fever - Therapeutics under Investigation by Universities/Institutes 11
Yellow Fever - Pipeline Products Glance 12
Clinical Stage Products 12
Early Stage Products 13
Yellow Fever - Products under Development by Companies 14
Yellow Fever - Products under Investigation by Universities/Institutes 15
Yellow Fever - Companies Involved in Therapeutics Development 16
Adamas Pharmaceuticals, Inc. 16
Arbovax, Inc. 17
BioCryst Pharmaceuticals, Inc. 18
iBio, Inc. 19
Johnson & Johnson 20
Myelo Therapeutics GmbH 21
NewLink Genetics Corporation 22
Panacea Biotec Limited 23
Themis Bioscience GmbH 24
Yellow Fever - Therapeutics Assessment 25
Assessment by Monotherapy Products 25
Assessment by Target 26
Assessment by Mechanism of Action 28
Assessment by Route of Administration 30
Assessment by Molecule Type 32
Drug Profiles 34
ADS-324 - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
BCX-4430 - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
BG-323 - Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
DiTU - Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
EMER-IT - Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
LCTA-949 - Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
Myelo-001 - Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
Small Molecule to Inhibit NS5 for Dengue and Flavivirus Infections - Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
yellow fever and arenavirus vaccine - Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
yellow fever vaccine - Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
yellow fever vaccine - Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
yellow fever vaccine - Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
yellow fever vaccine - Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
yellow fever vaccine - Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
yellow fever vaccine - Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
yellow fever vaccine (YF17D) - Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
Yellow Fever - Recent Pipeline Updates 51
Yellow Fever - Dormant Projects 54
Appendix 55
Methodology 55
Coverage 55
Secondary Research 55
Primary Research 55
Expert Panel Validation 55
Contact Us 55
Disclaimer 56

List of Tables
Number of Products under Development for Yellow Fever, H1 2015 8
Number of Products under Development for Yellow Fever - Comparative Analysis, H1 2015 9
Number of Products under Development by Companies, H1 2015 10
Number of Products under Investigation by Universities/Institutes, H1 2015 11
Comparative Analysis by Clinical Stage Development, H1 2015 12
Comparative Analysis by Early Stage Development, H1 2015 13
Products under Development by Companies, H1 2015 14
Products under Investigation by Universities/Institutes, H1 2015 15
Yellow Fever - Pipeline by Adamas Pharmaceuticals, Inc., H1 2015 16
Yellow Fever - Pipeline by Arbovax, Inc., H1 2015 17
Yellow Fever - Pipeline by BioCryst Pharmaceuticals, Inc., H1 2015 18
Yellow Fever - Pipeline by iBio, Inc., H1 2015 19
Yellow Fever - Pipeline by Johnson & Johnson, H1 2015 20
Yellow Fever - Pipeline by Myelo Therapeutics GmbH, H1 2015 21
Yellow Fever - Pipeline by NewLink Genetics Corporation, H1 2015 22
Yellow Fever - Pipeline by Panacea Biotec Limited, H1 2015 23
Yellow Fever - Pipeline by Themis Bioscience GmbH, H1 2015 24
Assessment by Monotherapy Products, H1 2015 25
Number of Products by Stage and Target, H1 2015 27
Number of Products by Stage and Mechanism of Action, H1 2015 29
Number of Products by Stage and Route of Administration, H1 2015 31
Number of Products by Stage and Molecule Type, H1 2015 33
Yellow Fever Therapeutics - Recent Pipeline Updates, H1 2015 51
Yellow Fever - Dormant Projects, H1 2015 54

List of Figures
Number of Products under Development for Yellow Fever, H1 2015 8
Number of Products under Development for Yellow Fever - Comparative Analysis, H1 2015 9
Number of Products under Development by Companies, H1 2015 10
Number of Products under Investigation by Universities/Institutes, H1 2015 11
Comparative Analysis by Early Stage Products, H1 2015 13
Assessment by Monotherapy Products, H1 2015 25
Number of Products by Top 10 Targets, H1 2015 26
Number of Products by Stage and Top 10 Targets, H1 2015 27
Number of Products by Top 10 Mechanism of Actions, H1 2015 28
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 29
Number of Products by Top 10 Routes of Administration, H1 2015 30
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 31
Number of Products by Top 10 Molecule Types, H1 2015 32
Number of Products by Stage and Top 10 Molecule Types, H1 2015 33

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2000 View Pricing